These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 34389338)
1. Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts. Xia B; Yang M; Nguyen LH; He Q; Zhen J; Yu Y; Di M; Qin X; Lu K; Kuo ZC; He Y; Zhang C; Meng W; Yuan J Gastroenterology; 2021 Dec; 161(6):1842-1852.e10. PubMed ID: 34389338 [TBL] [Abstract][Full Text] [Related]
2. Proton Pump Inhibitor Use Before and After a Diagnosis of Inflammatory Bowel Disease. Singh N; Nugent Z; Singh H; Shaffer SR; Bernstein CN Inflamm Bowel Dis; 2023 Dec; 29(12):1871-1878. PubMed ID: 36790051 [TBL] [Abstract][Full Text] [Related]
3. Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series. Varma S; Trudeau SJ; Li J; Freedberg DE Inflamm Bowel Dis; 2024 Jan; 30(1):38-44. PubMed ID: 36917215 [TBL] [Abstract][Full Text] [Related]
4. Confounded association between proton pump inhibitor use and risk of biliary tract cancer: Result from three cohorts. He Q; Huang C; Qin X; Yu Y; Tang D; Huang J; Kuo ZC; Ling Y; Mao D; Xia B; Li W; Lu K; Yang M; He Y; Meng W; Yuan J; Pan Y Int J Cancer; 2023 Sep; 153(5):942-949. PubMed ID: 37232081 [TBL] [Abstract][Full Text] [Related]
5. Gastric Acid Suppression Is Associated with an Increased Risk of Adverse Outcomes in Inflammatory Bowel Disease. Shah R; Richardson P; Yu H; Kramer J; Hou JK Digestion; 2017; 95(3):188-193. PubMed ID: 28288458 [TBL] [Abstract][Full Text] [Related]
6. Dietary Inflammatory Potential and Risk of Crohn's Disease and Ulcerative Colitis. Lo CH; Lochhead P; Khalili H; Song M; Tabung FK; Burke KE; Richter JM; Giovannucci EL; Chan AT; Ananthakrishnan AN Gastroenterology; 2020 Sep; 159(3):873-883.e1. PubMed ID: 32389666 [TBL] [Abstract][Full Text] [Related]
7. Intake of Ultra-processed Foods Is Associated with an Increased Risk of Crohn's Disease: A Cross-sectional and Prospective Analysis of 187 154 Participants in the UK Biobank. Chen J; Wellens J; Kalla R; Fu T; Deng M; Zhang H; Yuan S; Wang X; Theodoratou E; Li X; Satsangi J J Crohns Colitis; 2023 Apr; 17(4):535-552. PubMed ID: 36305857 [TBL] [Abstract][Full Text] [Related]
8. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort. Burisch J Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595 [TBL] [Abstract][Full Text] [Related]
9. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. Khalili H; Ananthakrishnan AN; Konijeti GG; Liao X; Higuchi LM; Fuchs CS; Spiegelman D; Richter JM; Korzenik JR; Chan AT BMJ; 2013 Nov; 347():f6633. PubMed ID: 24231178 [TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver degree and long-term risk of incident inflammatory bowel disease: A large-scale prospective cohort study. Zhang Q; Liu S; Wu J; Zhu S; Wu Y; Wu S; Zhang S Chin Med J (Engl); 2024 Jul; 137(14):1705-1714. PubMed ID: 37962217 [TBL] [Abstract][Full Text] [Related]
11. Increased risk of pneumonia among patients with inflammatory bowel disease. Long MD; Martin C; Sandler RS; Kappelman MD Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276 [TBL] [Abstract][Full Text] [Related]
12. Effects of proton pump inhibitors on inflammatory bowel disease: An updated review. Liang Y; Meng Z; Ding XL; Jiang M World J Gastroenterol; 2024 Jun; 30(21):2751-2762. PubMed ID: 38899331 [TBL] [Abstract][Full Text] [Related]
13. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies. Yuan J; He Q; Nguyen LH; Wong MCS; Huang J; Yu Y; Xia B; Tang Y; He Y; Zhang C Gut; 2021 Jun; 70(6):1070-1077. PubMed ID: 32989021 [TBL] [Abstract][Full Text] [Related]
14. Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank. Wu S; Xie S; Yuan C; Yang Z; Liu S; Zhang Q; Sun F; Wu J; Zhan S; Zhu S; Zhang S Inflamm Bowel Dis; 2023 Mar; 29(3):384-395. PubMed ID: 35639937 [TBL] [Abstract][Full Text] [Related]
15. Metabolic dysfunction-associated fatty liver disease and liver function markers are associated with Crohn's disease but not Ulcerative Colitis: a prospective cohort study. Chen J; Dan L; Tu X; Sun Y; Deng M; Chen X; Hesketh T; Li R; Wang X; Li X Hepatol Int; 2023 Feb; 17(1):202-214. PubMed ID: 36194337 [TBL] [Abstract][Full Text] [Related]
16. Microscopic Colitis and Risk of Inflammatory Bowel Disease in a Nationwide Cohort Study. Khalili H; Burke KE; Roelstraete B; Sachs MC; Olén O; Ludvigsson JF Gastroenterology; 2020 May; 158(6):1574-1583.e2. PubMed ID: 31926169 [TBL] [Abstract][Full Text] [Related]
17. Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease. Choden T; Zhang H; Sakuraba A Ann Med; 2023 Dec; 55(1):2198775. PubMed ID: 37070427 [TBL] [Abstract][Full Text] [Related]